ASTROTECH Corp Net Fee Amt
ASTROTECH Corp (ASTC) had Net Fee Amt of $27.62 thousand as of 2026-06-25, per its S-3 filed 2026-06-30.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-06-30
- 2026-06-25: Net Fee Amt $27.62K.
| Period end | Net Fee Amt |
|---|---|
| 2026-06-25 | $27.62K S-3 · filed 2026-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |